MedTrace Logo

A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers

NCT00386958 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 172

Last updated 2016-08-23

No results posted yet for this study

Summary

Bacterial corneal ulcers are a leading cause of pediatric blindness in underdeveloped countries due to a lack of antibiotic availability and affordability, among other reasons. Povidone-iodine, an inexpensive and readily available broad-spectrum antimicrobial agent, may be an effective and affordable treatment for corneal ulcers, allowing preservation of sight for those afflicted with this disease.

Conditions

  • Infected Corneal Ulcers
  • Bacterial Keratitis
  • Corneal Ulcer
  • Childhood Blindness

Interventions

DRUG

Povidone-Iodine

Sponsors & Collaborators

  • Thrasher Research Fund

    collaborator OTHER

  • Research to Prevent Blindness

    collaborator OTHER

  • University of California, Los Angeles

    collaborator OTHER

  • Kolokotrones Family Foundation

    collaborator UNKNOWN

  • University of the Philippines

    collaborator OTHER

  • L.V. Prasad Eye Institute

    collaborator OTHER

  • Joseph Eye Hospital

    collaborator OTHER

  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

    lead OTHER

Principal Investigators

  • Sherwin J. Isenberg, M.D. · Jules Stein Eye Institute and Harbor-UCLA Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Month
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-11-30
Primary Completion
2006-01-31
Completion
2006-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00386958 on ClinicalTrials.gov